DelveInsight's “Vitiligo Treatment Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

The trial judged the tolerability, safety and efficacy of atogepant, at 60 mg once daily, compared to the highest-tolerated ...

Johnson & Johnson (NYSE:JNJ) said that an advisory committee of the EU drug regulator, the European Medicines Agency (EMA), ...

Antibody drug conjugates, or ADCs, are still holding on to their spot as one of the hottest areas in cancer care—and AbbVie, ...

The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share.

Sector-by-sector analysis throws a spotlight on high-yielding winners in more defensive areas of the stock market.

A debate over the healthcare system erupted on X, pitting Mark Cuban against Elizabeth Warren over the root causes of soaring drug prices.

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

AbbVie stock danced a wild intraday tango on Tuesday, only to end up flat-footed at the closing bell. The day’s price swing ...

Grail announced that results from the registrational PATHFINDER 2 study of its Galleri multi-cancer early detection test ...